• LAST PRICE
    17.2400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    16.3700/ 1
  • Ask / Lots
    20.1800/ 4
  • Open / Previous Close
    0.0000 / 17.2400
  • Day Range
    ---
  • 52 Week Range
    Low 12.9500
    High 25.4700
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 16.78
TimeVolumeRCUS
09:32 ET510816.63
09:39 ET10016.72
09:41 ET130016.705
09:43 ET58716.785
09:45 ET123616.94
09:48 ET100016.98
09:50 ET290016.95
09:52 ET10016.995
09:56 ET20017.05
09:57 ET268717.145
09:59 ET25817.13
10:01 ET54317.16
10:03 ET341617.22
10:06 ET10017.22
10:08 ET782217.27
10:10 ET116017.23
10:14 ET34217.175
10:15 ET207617.1
10:17 ET60017.105
10:19 ET20017.075
10:21 ET80017.01
10:26 ET60016.99
10:32 ET23116.97
10:33 ET74716.97
10:35 ET134417.02
10:37 ET70217.05
10:39 ET20017.035
10:42 ET393917.06
10:44 ET10017.045
10:46 ET233317.04
10:48 ET151616.97
10:51 ET115017.02
10:55 ET70417.06
11:02 ET50017.11
11:04 ET10017.125
11:06 ET329517.18
11:08 ET43917.2
11:09 ET280517.25
11:11 ET30017.28
11:13 ET57717.29
11:15 ET75917.27
11:18 ET20017.31
11:20 ET10017.315
11:22 ET70017.32
11:24 ET79217.31
11:26 ET84017.295
11:27 ET10017.32
11:29 ET40017.32
11:31 ET80017.35
11:33 ET143517.305
11:36 ET75917.27
11:38 ET20017.31
11:40 ET60517.265
11:45 ET40017.25
11:47 ET10017.25
11:49 ET357917.31
11:51 ET200817.305
11:54 ET80017.3
11:56 ET113317.28
11:58 ET23317.2752
12:00 ET22017.26
12:02 ET30017.25
12:07 ET70017.22
12:09 ET30017.21
12:12 ET93117.24
12:14 ET120917.19
12:16 ET10017.14
12:20 ET22717.13
12:21 ET25717.1
12:25 ET211617.11
12:32 ET18117.1103
12:34 ET96617.12
12:36 ET310317.17
12:38 ET10017.18
12:39 ET10017.19
12:41 ET210017.17
12:43 ET10017.19
12:45 ET265817.17
12:48 ET110017.13
12:54 ET30017.1
12:56 ET30017.08
01:01 ET20017.05
01:03 ET20017.04
01:06 ET10417.03
01:08 ET60017.08
01:12 ET65017.09
01:14 ET10017.06
01:15 ET10017.09
01:19 ET10017.06
01:21 ET40017.06
01:24 ET10017.075
01:26 ET199817.081
01:28 ET50017.105
01:30 ET90017.15
01:33 ET205817.16
01:35 ET10017.17
01:42 ET20017.17
01:44 ET80017.24
01:46 ET100417.215
01:48 ET10017.22
01:51 ET20017.215
01:53 ET223617.185
01:55 ET10017.19
02:04 ET49117.195
02:06 ET141917.17
02:09 ET80617.2
02:13 ET20017.19
02:15 ET20017.19
02:20 ET161317.215
02:22 ET83017.21
02:24 ET70617.19
02:26 ET138617.171
02:27 ET10017.17
02:31 ET31317.17
02:33 ET81417.19
02:36 ET170017.21
02:38 ET166617.17
02:40 ET37417.17
02:42 ET30017.17
02:49 ET504617.23
02:51 ET10017.25
02:54 ET113017.29
02:56 ET20017.31
02:58 ET200417.33
03:02 ET191217.315
03:03 ET10017.33
03:05 ET10017.325
03:07 ET20017.31
03:09 ET10017.34
03:12 ET72017.36
03:14 ET88117.38
03:18 ET121517.39
03:20 ET162417.38
03:21 ET20017.39
03:23 ET14217.3944
03:25 ET101017.37
03:27 ET203217.38
03:30 ET22617.42
03:32 ET10017.42
03:34 ET817617.331
03:36 ET1055217.31
03:38 ET68817.27
03:39 ET199417.3
03:41 ET110017.305
03:43 ET558917.25
03:45 ET465817.27
03:48 ET361317.245
03:50 ET774117.27
03:52 ET1341717.3
03:54 ET496217.295
03:56 ET2255917.36
03:57 ET3290417.305
03:59 ET5492917.24
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRCUS
Arcus Biosciences Inc
1.6B
-5.6x
---
United StatesARDX
Ardelyx Inc
1.8B
-26.8x
---
United StatesVIR
Vir Biotechnology Inc
1.4B
-2.5x
---
United StatesXNCR
Xencor Inc
1.5B
-10.8x
---
United StatesGYRE
Gyre Therapeutics Inc
1.1B
-7.0x
---
United StatesPRTA
Prothena Corporation PLC
1.2B
-6.7x
---
As of 2024-05-22

Company Information

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.

Contact Information

Headquarters
3928 Point Eden WayHAYWARD, CA, United States 94545-3719
Phone
510-694-6200
Fax
302-730-1370

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Terry Rosen
President, Co-Founder
Juan Jaen
Chief Financial Officer
Robert Goeltz
Chief Operating Officer
Jennifer Jarrett
Chief Accounting Officer
Alexander Azoy

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6B
Revenue (TTM)
$237.0M
Shares Outstanding
91.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.88
EPS
$-3.10
Book Value
$6.12
P/E Ratio
-5.6x
Price/Sales (TTM)
6.6
Price/Cash Flow (TTM)
---
Operating Margin
-113.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.